EUVIMEDEUVIMED entdecken
Crossref

Potential of hTERT mRNA for the management of advanced head and neck squamous cell carcinoma.

Blanca Pilar Galindo Torres, Raquel Alcaraz Ortega, Patricia Saiz López, María Isabel Adiego Leza, Carlos García Girón, Miguel Víctor Grijalba Uche

European Archives of Oto-Rhino-Laryngology · 2026

DOI: 10.1007/s00405-026-10477-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2026. Verfasst von Blanca Pilar Galindo Torres und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio Otorrinolaringología, Hospital Universitario de Burgos, Burgos, Spain. bgalindot@saludcastillayleon.es. Hauptthemen laut MEDLINE: Telomerase, RNA, Messenger, Head and Neck Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Fundación Burgos por Investigación de la Salud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose hTERT messenger RNA (hTERT mRNA) has been detected in peripheral blood of different cancer patients and its elevation seems related to clinicopathological parameters and treatment efficacy. The objectives are analyzing if hTERT mRNA levels are increased in cancer patients, detecting it they change after treatment and determining if they could be useful in disease monitoring.

Methods

A prospective, analytical, case-control study was conducted, in which peripheral blood of 37 head and neck squamous cell cancer patients and 30 healthy donors were obtained. hTERT mRNA expression levels were determined by PCR-RT. Follow-up of cancer patients was carried out during one year with blood extractions at 7 days for surgical patients, and 1, 2, 6 and 12 months after finishing treatment for all patients. Results hTERT mRNA expression levels were elevated in plasma of cancer patients (0,75) compared to controls (0,5) ( p = 0.003). Patients in more advanced stages had higher hTERT mRNA levels ( p = 0.008). hTERT mRNA levels during follow-up did not change significantly at the different time points but showed a tendency to decrease, comparing treatment responders with tumour persistence patients. An early decrease of hTERT mRNA levels was observed in the five cured patients who underwent surgery.

Conclusions

Detection of plasma hTERT mRNA after surgery might help to identify patients with better prognosis. Quantitation of plasma hTERT mRNA could be a complementary tool for diagnosis, but still further studies are needed to clarify the role and causes of variable circulating hTERT mRNA levels for prognosis and follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseRNA, MessengerHead and Neck NeoplasmsCarcinoma, Squamous CellBiomarkers, TumorHumansFemaleMaleMiddle AgedProspective StudiesCase-Control StudiesNeoplasm StagingAgedAdultPrognosisSquamous Cell Carcinoma of Head and Neck

Stichwörter der Autor:innen

DiagnosisHead and neck squamous cell cancerMonitoringPlasma hTERT mRNAPrognosis

Substanzen

TelomeraseRNA, MessengerTERT protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Servicio Otorrinolaringología, Hospital Universitario de Burgos, Burgos, Spain. bgalindot@saludcastillayleon.es.
  • Otolaryngology Department, block F, 6th floor Av. Islas Baleares, 3, Burgos, 09006, Spain. bgalindot@saludcastillayleon.es.
  • Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain.
  • Servicio Anatomía Patológica, Hospital Universitario de Burgos, Burgos, Spain.
  • Servicio Otorrinolaringología, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Servicio Oncología Médica, Hospital Universitario de Burgos, Burgos, Spain.

Förderung

  • Fundación Burgos por Investigación de la Salud

Zitieren

APA

Galindo Torres, B. P., Alcaraz Ortega, R., Saiz López, P., Adiego Leza, M. I., García Girón, C., & Grijalba Uche, M. V. (2026). Potential of hTERT mRNA for the management of advanced head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-026-10477-5

Vancouver

Galindo Torres BP, Alcaraz Ortega R, Saiz López P, Adiego Leza MI, García Girón C, Grijalba Uche MV. Potential of hTERT mRNA for the management of advanced head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-026-10477-5

BibTeX
@article{GalindoTorres2026,
  author = {Galindo Torres, Blanca Pilar and Alcaraz Ortega, Raquel and Saiz López, Patricia and Adiego Leza, María Isabel and García Girón, Carlos and Grijalba Uche, Miguel Víctor},
  title = {Potential of hTERT mRNA for the management of advanced head and neck squamous cell carcinoma},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  doi = {10.1007/s00405-026-10477-5}
}
Kostenlos starten →